News Focus
News Focus
icon url

manibiotech

12/23/25 8:37 AM

#804302 RE: The Danish Dude #804300

Ohh boy .... thank you for your service .
So why didn't they apply to FDA. LG said on phone in no uncertain terms that applicantion to FDA will be alongside MHRA. 
icon url

Doc logic

12/23/25 9:55 AM

#804305 RE: The Danish Dude #804300

The Danish Dude,

Look! Gary was correct! Dr. Linda Liau said “…it is feasible to have this vaccine manufactured at 94 centers.” Point of service language! Sorry biosectinvestor but this point goes to Gary. Now how do you do this without increasing very expensive Class B clean room space? Hmmm. Manufacturing, manufacturing, manufacturing. Class C clean room space being built out now. Gee, what could that be for?; ). Best wishes.
icon url

learningcurve2020

12/23/25 10:10 AM

#804310 RE: The Danish Dude #804300

You should’ve dated these transcripts. Since T cell therapy has shown improvement in GBM. And with the confusion on pseudo progression we don’t know how many non progression patients actually moved into the L arm, and why the control depleted?

This one always bother me. I agree, it is surprising…and worrisome, imo.

>>Dr. Liau: Surprisingly, no. We actually—there was actually very good tolerability for the vaccine and the safety profile was exceptionally benign.
icon url

hankmanhub

12/23/25 11:50 AM

#804323 RE: The Danish Dude #804300

please provide the date and time of both the interview and transcript.
icon url

Investor082

12/23/25 1:49 PM

#804359 RE: The Danish Dude #804300

LOL, no one is interested in your free service! They would have lost more than 70% if they listened to you 3 years ago.

We are looking forward to yet another of your post in 2026 bragging about averaging down and how you beat the market to it, LOL! ;) LP won’t disappoint!